Literature DB >> 11902681

Embryonic expression of Xenopus SGLT-1L, a novel member of the solute carrier family 5 (SLC5), is confined to tubules of the pronephric kidney.

Samer R Eid1, Anne Terrettaz, Katsumi Nagata, André W Brändli.   

Abstract

Plasma membrane proteins of the solute carrier family 5 (SLC5) are responsible for sodium-coupled uptake of ions, sugars and nutrients in the vertebrate body. Mutations in SLC5 genes are the cause of several inherited human disorders. We have recently reported the cloning and transport properties of SGLT-1L, a Xenopus homologue of the sodium-dependent glucose cotransporter 1 (SGLT-1) [Nagata et al. (1999) Am. J. Physiol. 276: G1251 -G 1259]. Here, we describe the phylogenetic relationship of SGLT-1L with other members of the SLC5 family and characterize its expression during Xenopus embryogenesis and in organ cultures. Sequence comparisons and phylogenetic analyses of all known vertebrate SLC5 sequences indicated that Xenopus SGLT-1L encodes a novel SLC5 member, which shares highest amino acid identity with mammalian ST-1 proteins. Temporal and spatial expression of SGLT-1L during Xenopus embryogenesis was examined by whole mount in situ hybridization. Initiation of SGLT-1L expression occurred in the late tailbud embryo. Remarkably, expression was restricted to the developing pronephric kidney. SGLT-1L was highly expressed in tubular epithelia, but completely absent from the epithelia of the duct. Analysis of growth factor-treated animal caps indicated that expression of SGLT-1L could also be induced in organ cultures. Taken together, our findings indicate that the expression of sodium-dependent solute cotransporter genes in early segments of the excretory system appears to be conserved between pronephric and metanephric kidneys. Furthermore, we establish SGLT-1L as a novel, highly specific molecular marker for pronephric tubule epithelia undergoing maturation and terminal differentiation in Xenopus.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11902681

Source DB:  PubMed          Journal:  Int J Dev Biol        ISSN: 0214-6282            Impact factor:   2.203


  7 in total

Review 1.  Xenopus pronephros development--past, present, and future.

Authors:  Oliver Wessely; Uyen Tran
Journal:  Pediatr Nephrol       Date:  2011-04-17       Impact factor: 3.714

2.  The prepattern transcription factor Irx3 directs nephron segment identity.

Authors:  Luca Reggiani; Daniela Raciti; Rannar Airik; Andreas Kispert; André W Brändli
Journal:  Genes Dev       Date:  2007-09-15       Impact factor: 11.361

3.  Gene expression analysis defines the proximal tubule as the compartment for endocytic receptor-mediated uptake in the Xenopus pronephric kidney.

Authors:  Erik I Christensen; Daniela Raciti; Luca Reggiani; Pierre J Verroust; André W Brändli
Journal:  Pflugers Arch       Date:  2008-06-13       Impact factor: 3.657

4.  Programming pluripotent precursor cells derived from Xenopus embryos to generate specific tissues and organs.

Authors:  Annette Borchers; Tomas Pieler
Journal:  Genes (Basel)       Date:  2010-11-18       Impact factor: 4.096

Review 5.  Modeling congenital kidney diseases in Xenopus laevis.

Authors:  Alexandria T M Blackburn; Rachel K Miller
Journal:  Dis Model Mech       Date:  2019-04-09       Impact factor: 5.758

6.  Evolution and developmental expression of the sodium-iodide symporter (NIS, slc5a5) gene family: Implications for perchlorate toxicology.

Authors:  Ann M Petersen; Clayton M Small; Yi-Lin Yan; Catherine Wilson; Peter Batzel; Ruth A Bremiller; C Loren Buck; Frank A von Hippel; William A Cresko; John H Postlethwait
Journal:  Evol Appl       Date:  2022-07-07       Impact factor: 4.929

7.  Organization of the pronephric kidney revealed by large-scale gene expression mapping.

Authors:  Daniela Raciti; Luca Reggiani; Lars Geffers; Qiuhong Jiang; Francesca Bacchion; Astrid E Subrizi; Dave Clements; Christopher Tindal; Duncan R Davidson; Brigitte Kaissling; André W Brändli
Journal:  Genome Biol       Date:  2008-05-20       Impact factor: 13.583

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.